More advanced versions, so-called helper-dependent adenoviral (HDAd) vectors, were depleted of all viral coding sequences.40,44 The first, albeit not placebo-controlled, CF gene therapy trial was reported by Zabner and colleagues in 1993, only 4 years after cloning the CFTR gene. This evidence concerns the gene CFTR and cystic fibrosis.